Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine,Neurology (clinical)
Reference5 articles.
1. Welling LC, Rabelo NN, Aguiar LB, et al. Intravenous nimodipine versus enteral nimodipine: the meta-analysis paradox. Neurocrit Care. 2022. https://doi.org/10.1007/s12028-022-01589-x.
2. Geraldini F, De Cassai A, Diana P, et al. A comparison between enteral and intravenous nimodipine in subarachnoid hemorrhage: a systematic review and network meta-analysis. Neurocrit Care. 2022;36(3):1071–9. https://doi.org/10.1007/s12028-022-01493-4.
3. Andersen CR, Fitzgerald E, Delaney A, Finfer S. A systematic review of outcome measures employed in aneurysmal subarachnoid hemorrhage (aSAH) clinical research. Neurocrit Care. 2019;30(3):534–41.
4. Mees DSM, Rinkel GJE, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;3:CD000277. https://doi.org/10.1002/14651858.CD000277.pub3.
5. Altman D, Ashby D, Birks J, et al. Chapter 10: analysing data and undertaking meta-analyses. In: Deeks JJ, Higgins JPT, Altman DG, et al., editors. Cochrane Handbook for systematic reviews of interventions version 6.3. Cochrane, 2022. www.training.cochrane.org/handbook. Cited 5 Aug 2022.